IP Library Granted Patent US 9,801,954
Granted Patent B2
US 9,801,954 · App. 15/034,425 · Granted Oct 31, 2017

Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression

Inventors: Kaushal Rege (Chandler, AZ); Bhavani Miryala (Tempe, AZ); Thrimoorthy Potta (Phoenix, AZ)
Assignee: Arizona Board of Regents on Behalf of Arizona State University
A61K48/0041A61K47/4823A61K47/48046A61K47/48192C12N15/87
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,801,954
App. No.
15/034,425
Granted
Oct 31, 2017
Kind
B2
Abstract

A method to form a lipid-containing aminoglycoside-based polymer, where the method includes reacting an aminoglycoside with a diepoxide to form an aminoglycoside-based polymeric material, and then reacting the aminoglycoside-based polymeric material with an acyl chloride to form the lipid-containing aminoglycoside-based polymer.

Claims (23)

1. A method to form an aminoglycoside based polymer, comprising:

reacting an aminoglycoside having a structure:

wherein R 1 is an aminoglycoside monomer, with a diepoxide having a structure:

wherein R 2 is a backbone of said diepoxide, to form an aminoglycoside-based polymeric material having a structure:

wherein n is between about 3 and about 10.

2. The method of claim 1 , further comprising reacting said aminoglycoside-based polymeric material with an acyl chloride having a structure:

wherein R 3 is an alkyl group comprising C 6 , C 14 , or C 18 , to form a lipid-containing aminoglycoside polymer having a structure:

3. The method of claim 1 , wherein said aminoglycoside comprises neomycin.

4. The method of claim 1 , wherein said aminoglycoside comprises paromomycin.

5. The method of claim 1 , wherein said aminoglycoside comprises apramycin.

6. The method of claim 1 , wherein said diepoxide comprises glycerol diglycidyl ether.

7. The method of claim 1 , wherein said diepoxide comprises resorcinol diglycidyl ether.

8. The method of claim 2 , wherein the molar ratio of said acyl chloride to said aminoglycoside-based polymeric material is about 1:2.

9. The method of claim 2 , wherein the molar ratio of said acyl chloride to said aminoglycoside-based polymeric material is about 1:5.

10. The method of claim 2 , wherein the molar ratio of said acyl chloride to said aminoglycoside-based polymeric material is about 1:10.

11. The method of claim 2 , wherein R 3 comprises a C6 hydrocarbon.

12. The method of claim 2 , wherein R 3 comprises a C18 hydrocarbon.

13. A lipid-conjugated polymer, coprising:

wherein R 1 is an aminoglycoside monomer, R 2 is a backbone of a diepoxide, and R 3 is an alkyl group comprising C6, C14, or C18.

14. A method to form an aminoglycoside based polymer, comprising:

reacting an aminoglycoside with a diepoxide in a solvent system of DMSO to form an aminoglycoside-based polymeric material.

15. The method of claim 14 , further comprising reacting said aminoglycoside-based polymeric material with an acyl chloride to form a lipid-containing aminoglycoside polymer.

16. The method of claim 14 , wherein the diepoxide comprises diglycidyl ether.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 7, 2016
From: ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039277/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2016
From: REGE, KAUSHAL; MIRYALA, BHAVANI; POTTA, THRIMOORTHY
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 038457/0579 →
Continuity (2)
Provisional Application 61899986 · Nov 5, 2013
Related Publication 20160279264A1 · Sep 29, 2016